Kang Y, Varghese P, Al Aiyan A, Pondman K, Kishore U, Sim R
Front Immunol. 2024; 15:1368852.
PMID: 38933264
PMC: 11199686.
DOI: 10.3389/fimmu.2024.1368852.
Motta C, Pellegrini A, Camaione S, Geoghegan J, Speziale P, Barbieri G
Sci Rep. 2023; 13(1):11683.
PMID: 37468579
PMC: 10356753.
DOI: 10.1038/s41598-023-38972-3.
Poole L, Schmitt L, Schulte A, Groeneveld D, Cline H, Sang Y
J Thromb Haemost. 2023; 21(8):2175-2188.
PMID: 37062522
PMC: 10524487.
DOI: 10.1016/j.jtha.2023.04.003.
Semkova M, Hsuan J
Proteomes. 2021; 9(4).
PMID: 34842803
PMC: 8628943.
DOI: 10.3390/proteomes9040043.
Gaule T, Ajjan R
Int J Mol Sci. 2021; 22(13).
PMID: 34203139
PMC: 8268464.
DOI: 10.3390/ijms22136916.
Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
Duval C, Baranauskas A, Feller T, Ali M, Cheah L, Yuldasheva N
Proc Natl Acad Sci U S A. 2021; 118(27).
PMID: 34183396
PMC: 8271579.
DOI: 10.1073/pnas.2103226118.
The Nature of Resistance of the Coagulation Factor XIII Structure to Hypochlorite-Induced Oxidation.
Vasilyeva A, Yurina L, Bugrova A, Indeykina M, Kononikhin A, Schegolikhin A
Dokl Biochem Biophys. 2020; 495(1):276-281.
PMID: 33368034
DOI: 10.1134/S1607672920050117.
Blood Clot Phenotyping by Rheometry: Platelets and Fibrinogen Chemistry Affect Stress-Softening and -Stiffening at Large Oscillation Amplitude.
Windberger U, Lauger J
Molecules. 2020; 25(17).
PMID: 32858936
PMC: 7503632.
DOI: 10.3390/molecules25173890.
The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation.
Vasilyeva A, Yurina L, Shchegolikhin A, Indeykina M, Bugrova A, Kononikhin A
Biomolecules. 2020; 10(6).
PMID: 32560304
PMC: 7355775.
DOI: 10.3390/biom10060914.
Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
Mouapi K, Wagner L, Stephens C, Hindi M, Wilkey D, Merchant M
Thromb Haemost. 2019; 119(7):1048-1057.
PMID: 31055797
PMC: 7340171.
DOI: 10.1055/s-0039-1687875.
Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.
Schmitt L, Henderson R, Barrett A, Darula Z, Issaian A, DAlessandro A
J Biol Chem. 2019; 294(22):8773-8778.
PMID: 31028172
PMC: 6552431.
DOI: 10.1074/jbc.AC119.007981.
Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions.
Sivado E, El Alaoui M, Kiraly R, Fesus L, Delolme F, Page A
FEBS Open Bio. 2019; 9(2):396-404.
PMID: 30761263
PMC: 6356169.
DOI: 10.1002/2211-5463.12575.
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration.
Ryu J, Rafalski V, Meyer-Franke A, Adams R, Poda S, Rios Coronado P
Nat Immunol. 2018; 19(11):1212-1223.
PMID: 30323343
PMC: 6317891.
DOI: 10.1038/s41590-018-0232-x.
Biophysical Mechanisms Mediating Fibrin Fiber Lysis.
Hudson N
Biomed Res Int. 2017; 2017:2748340.
PMID: 28630861
PMC: 5467299.
DOI: 10.1155/2017/2748340.
Nonlinear mechanics of hybrid polymer networks that mimic the complex mechanical environment of cells.
Jaspers M, Vaessen S, van Schayik P, Voerman D, Rowan A, Kouwer P
Nat Commun. 2017; 8:15478.
PMID: 28541273
PMC: 5458517.
DOI: 10.1038/ncomms15478.
Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.
Mouapi K, Bell J, Smith K, Ariens R, Philippou H, Maurer M
Blood. 2016; 127(18):2241-8.
PMID: 26951791
PMC: 4859198.
DOI: 10.1182/blood-2015-09-672303.
Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.
Kogan A, Mukharyamova K, Bereznikova A, Filatov V, Koshkina E, Bloshchitsyna M
Blood Coagul Fibrinolysis. 2015; 27(5):542-50.
PMID: 26656897
PMC: 4935535.
DOI: 10.1097/MBC.0000000000000453.
Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing.
Zuliani-Alvarez L, Midwood K
Adv Wound Care (New Rochelle). 2015; 4(5):273-285.
PMID: 26005593
PMC: 4432967.
DOI: 10.1089/wound.2014.0599.
Elimination of coagulation factor XIII from fibrinogen preparations.
Smith E, Cardinali B, Ping L, Ariens R, Philippou H
J Thromb Haemost. 2013; 11(5):993-5.
PMID: 23413924
PMC: 3656969.
DOI: 10.1111/jth.12174.
Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.
Wang W
J Biol Chem. 2011; 286(52):44952-64.
PMID: 22030394
PMC: 3248016.
DOI: 10.1074/jbc.M111.297119.
